Paul Rivard - Jun 7, 2023 Form 4 Insider Report for MyMD Pharmaceuticals, Inc. (MYMD)

Role
Chief Legal Officer
Signature
/s/ Paul Rivard
Stock symbol
MYMD
Transactions as of
Jun 7, 2023
Transactions value $
$0
Form type
4
Date filed
6/9/2023, 06:00 PM
Previous filing
Dec 8, 2022
Next filing
Aug 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYMD Employee Stock Option (Right to Buy) Award $0 +150K $0.00 150K Jun 7, 2023 Common Stock 150K $1.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date.